Company Overview of Nektar Therapeutics
Independent Director, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 6 different industries.|
See Board Relationships
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships
EducationThere is no Education data available.
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Mark R. Baker J.D.||Chief Executive Officer and Director|
Progenics Pharmaceuticals, Inc.
|Craig Alexander Collard||Chief Executive Officer and President|
Veloxis Pharmaceuticals A/S
|Michael T. Heffernan B.S. Pharm, R.Ph.||Founder, Chairman, Chief Executive Officer, President, Treasurer and Secretary|
Collegium Pharmaceutical, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President and Director|
Emergent BioSolutions Inc.
|Stephen J. Farr Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
|$468.8K||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.